R
ROIV
Roivant Sciences
11.92
0.11+0.93%After Hours: 11.95 +0.03 +0.25%16:54 08/22 EDT
OPEN/PREV CLOSE11.85/11.81
TODAY RANGE11.82-12.03
VOL4.90M
MARKET CAP8.14B
52 WEEK RANGE8.73-13.06
AVG VOL (3M)5.85M
% TURNOVER0.72%
TURNOVER--
P/E (TTM)-17.0603
% RANGE1.61%
EPS(TTM)-0.6987
P/E(FORWARD)-8.9962
P/B1.871
BVPS6.37
DIVIDEND--
P/S285.85
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.11B
SHARES OUTSTANDING682.88M
NEXT EARNINGS11/10-11/14
FREE FLOAT428.86M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
3 Stocks to Buy Now, According to the Technical Analysis
Seeking Alpha·08/15 13:30
Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst Stack
Simply Wall St·08/13 06:27
Roivant Sciences’ (ROIV) Aggressive Buybacks Amid Losses: Commitment to Shareholders or Growth Uncertainty?
TipRanks·08/13 02:30
Roivant Sciences Earnings Call: Progress Amid Challenges
TipRanks·08/12 18:25
Leerink Partners Keeps Their Buy Rating on Roivant Sciences (ROIV)
TipRanks·08/12 11:46
Guggenheim Sticks to Its Buy Rating for Roivant Sciences (ROIV)
TipRanks·08/12 04:14
Roivant Sciences Reports Q1 2025 Financial Results
TipRanks·08/11 21:55
TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)
NASDAQ·08/11 20:58
Why Roivant Sciences Stock Was Slipping on Monday
Seeking Alpha·08/11 16:29
Roivant plans $500M new share repurchase as brepocitinib data readout nears
NASDAQ·08/11 12:15
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
Reuters·08/11 11:13
Biopharma firm Roivant's Q1 revenue declines, net loss widens to $273.9 mln
TipRanks·08/11 11:11
Roivant Sciences reports Q1 EPS (33c), consensus (23c)
Dow Jones·08/11 11:07
*Roivant Sciences 1Q Loss/Shr 33c >ROIV
Same Industry
Name/Symbol
Change%
Price